Literature DB >> 11487270

Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.

M T Salmela1, M L Karjalainen-Lindsberg, P Puolakkainen, U Saarialho-Kere.   

Abstract

Oesophageal adenocarcinoma is believed to arise from metaplastic mucosa in the distal oesophagus, a condition also known as Barrett's oesophagus (BE). BE develops as a result of injury caused by refluxing gastric and duodenal contents and is associated with increased risk of malignant transformation. Matrix metalloproteinases (MMPs) have been implicated in all aspects of tumour progression; tumour growth, basement membrane degradation, invasion and metastatic spread. Using in situ hybridization, we investigated the expression patterns of collagenases-1 and -3, stromelysin-2, matrilysin, metalloelastase and TIMPs-1 and -3 in BE, adenocarcinoma and lymph-node metastases. Matrilysin was expressed abundantly in 12/15 tumours and in 4/6 lymph-node metastases and its expression correlated with the histological aggressiveness of tumour. Matrilysin and metalloelastase were upregulated already in BE. Stromelysin-2 and collagenase-3 expression was detected only in a few tumours. Collagenase-1 was expressed by cancer and stromal cells in 9/15 tumours. Tumour-infiltrating macrophages expressed metalloelastase in 13/15 cancers. TIMPs-1 and -3 were expressed in 12/15 and 11/15 tumours, respectively. Laminin-5 and tenascin were abundantly expressed at the invasive front of poorly differentiated tumours, but not in BE. Our results indicate that matrilysin is the principal MMP expressed by tumour cells in oesophageal adenocarcinoma, and further studies are needed to investigate whether matrilysin or tenascin-C could be used as a predictive marker for progression of BE to cancer. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487270      PMCID: PMC2364078          DOI: 10.1054/bjoc.2001.1929

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  54 in total

1.  Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

Authors:  G Murphy; M I Cockett; R V Ward; A J Docherty
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

2.  Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.

Authors:  K Ohashi; T Nemoto; K Nakamura; R Nemori
Journal:  Cancer       Date:  2000-05-15       Impact factor: 6.860

3.  Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages.

Authors:  M W Feinberg; M K Jain; F Werner; N E Sibinga; P Wiesel; H Wang; J N Topper; M A Perrella; M E Lee
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

Review 4.  Morphology of Barrett's esophagus and Barrett's-associated dysplasia and adenocarcinoma.

Authors:  D A Antonioli; H H Wang
Journal:  Gastroenterol Clin North Am       Date:  1997-09       Impact factor: 3.806

5.  Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.

Authors:  K Yamashita; M Mori; T Shiraishi; K Shibuta; K Sugimachi
Journal:  Clin Cancer Res       Date:  2000-03       Impact factor: 12.531

6.  Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor.

Authors:  H I Park; J Ni; F E Gerkema; D Liu; V E Belozerov; Q X Sang
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

7.  Laminin-5 as a marker of invasiveness in cervical lesions.

Authors:  B Skyldberg; S Salo; E Eriksson; U Aspenblad; B Moberger; K Tryggvason; G Auer
Journal:  J Natl Cancer Inst       Date:  1999-11-03       Impact factor: 13.506

Review 8.  Malignant progression in Barrett's esophagus: pathology and molecular biology.

Authors:  J Mueller; M Werner; J R Siewert
Journal:  Recent Results Cancer Res       Date:  2000

9.  Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness.

Authors:  T Etoh; H Inoue; Y Yoshikawa; G F Barnard; S Kitano; M Mori
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

10.  Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.

Authors:  E Kerkelä; R Ala-aho; J Lohi; R Grénman; V M-Kähäri; U Saarialho-Kere
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

View more
  33 in total

Review 1.  Optical molecular imaging for detection of Barrett's-associated neoplasia.

Authors:  Nadhi Thekkek; Sharmila Anandasabapathy; Rebecca Richards-Kortum
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

Review 2.  Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.

Authors:  Bita V Naini; Rhonda F Souza; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2016-05       Impact factor: 6.394

3.  Towards the molecular characterization of disease: comparison of molecular and histological analysis of esophageal epithelia.

Authors:  Daniel Vallböhmer; Paul Marjoram; Hidekazu Kuramochi; Daisuke Shimizu; Hsuan Jung; Steve R DeMeester; Daniel Oh; Parakrama T Chandrasoma; Kathleen D Danenberg; Tom R DeMeester; Peter V Danenberg; Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

Review 4.  Laminin-332-integrin interaction: a target for cancer therapy?

Authors:  Daisuke Tsuruta; Hiromi Kobayashi; Hisayoshi Imanishi; Koji Sugawara; Masamitsu Ishii; Jonathan C R Jones
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

5.  Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.

Authors:  Laszlo Herszenyi; Istvan Hritz; Istvan Pregun; Ferenc Sipos; Mark Juhasz; Bela Molnar; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

6.  Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma.

Authors:  Winson Y Cheung; Rihong Zhai; Penny Bradbury; Jessica Hopkins; Matthew H Kulke; Rebecca S Heist; Kofi Asomaning; Clement Ma; Wei Xu; Zhaoxi Wang; Suzanne Hooshmand; Li Su; David C Christiani; Geoffrey Liu
Journal:  Int J Cancer       Date:  2012-04-24       Impact factor: 7.396

Review 7.  The history of matrix metalloproteinases: milestones, myths, and misperceptions.

Authors:  Rugmani Padmanabhan Iyer; Nicolle L Patterson; Gregg B Fields; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

Review 8.  Reflux esophagitis, high-grade neoplasia, and early Barrett's carcinoma-what is the place of the Merendino procedure?

Authors:  A H Hölscher; D Vallböhmer; C Gutschow; E Bollschweiler
Journal:  Langenbecks Arch Surg       Date:  2008-11-07       Impact factor: 3.445

9.  Matrix metalloproteinase 1: role in sarcoma biology.

Authors:  Muhammad Umar Jawad; Nandor Garamszegi; Susanna P Garamszegi; Mayrin Correa-Medina; Juan A Diez; Rong Wen; Sean P Scully
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

10.  Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue.

Authors:  Edmond Sabo; Patricia A Meitner; Rosemarie Tavares; Christopher L Corless; Gregory Y Lauwers; Steven F Moss; Murray B Resnick
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.